Rifaximin for active ulcerative colitis
Open Access
- 1 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 12 (4), 335
- https://doi.org/10.1097/01.mib.0000215092.85116.6c
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- An open-label evaluation of rifaximin in the treatment of active Crohn's diseaseCurrent Medical Research and Opinion, 2005
- Antibiotics for inflammatory bowel disease: do they work?European Journal of Gastroenterology & Hepatology, 2005
- Dysbiosis in inflammatory bowel diseaseGut, 2004
- Mucosal flora in inflammatory bowel diseaseGastroenterology, 2002
- RifaximinDrugs, 1995
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989